TF and cancer: Interestingly, Gomes and colleagues proved that not only cancer cells, but also cancer cell-derived extracellular vesicles (EVs), with a high surface expression of TF, can induce TF-dependent plasma clotting and platelet aggregation by means of thrombin generation, in addition to the TF-independent mechanism of platelet activation expressed by these vesicles [64].